This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. The groundbreaking study conducted by New Frontier Data surveyed over 3,000 adult Americans to show people from all age groups and demographics in the U.S. Consumer Profiles. Legalization. appeared first on Leaf Science.
MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .
There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. Furthermore, Virginia’s consumption/product regulations are smoke-free. ” and “We only want to see data from an American source.”
Medicann is launching an observational study using RYAH Smart Dry Herb Inhalers in order to collect patient feedback on consumption of cannabis strains available on the Island, including strains supplied by Aurora Europe , a subsidiary of Canadian-headquartered Aurora Cannabis Inc., About RYAH Group, Inc. RYAH Group, Inc.
Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs.
A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. The brief survey can be taken here.
The news outlet used data from Headset to explain that Gen Z women who purchased cannabis grew by 151%, with the Gen Z men sitting at a 118% increase in legal purchases. According to the Headset data, flower purchases dominate in both genders but women tend to navigate towards pre-rolled joints, edibles, and beverages more than men.
There is not extensive safety data available, however. Nanoemulsions can improve the bioavailability of pharmaceuticals and their uptake, and require less energy to break them down. The various methods of cannabis consumption have different levels of bioavailability. Nanoemulsion and the bioavailability of cannabis.
Four times the energy as the pharmaceutical industry. pharmaceutical industry energy expenditure. A 2018 study by Frontier Data found that combined with illegal cultivation, the total electricity consumption by cannabis production climbs to 4.1 But there’s a price. Outdoor cultivation isn’t always much better.
In May 2021, the licensed pharmaceutical wholesaler, importer, and manufacturer was featured on the Düsseldorf Stock Exchange. Something that is contributing to market growth is the consistent supply of pharmaceutical cannabis, as well as the prospect of an adult-use cannabis market. billion (USD$8.4 billion) by 2028.
Most commonly, pharmaceutical medication is prescribed to regulate moods. However, pharmaceutical medications can have side effects, and they may take longer to work for many patients. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.
Varied personal accounts of cannabis consumption causing a wide range of urinary effects have included but are not limited to: being unable to pee while feeling a strong urge to pee, peeing caused by laughter, and multiple sclerosis patients learning their cannabis medication also helps reduce the number of times they have to run to the bathroom.
The disparities in consumption could be attributed to the fact that Japan implements harsh laws forbidding the use, production, and importation of illicit substances. Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. Based on a report published by the committee, a mere 1.4%
However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5.
In its Constituent Update, the FDA states broadly that the companies are selling CBD products “that people may confuse for traditional foods or beverages which may result in unintentional consumption or overconsumption of CBD.” [1]. CBD manufacturers, wholesalers, and retailers need to be vigilant of FDA policy changes on CBD.
The North American College of Pharmaceutical Technology (NACPT) is conducting a pilot series of professionals in medical cannabis workshops, and we spent a day learning and discussing food safety, regulatory tech, processes and systems. Is there historical, prospective and current data to be mined? (in bud/pre-roll/vapes/ etc.).
Eybna utilizes ethnobotany as an observational and analytical approach to medical cannabis usage data. This data is gathered, analyzed, and applied to complimentary product development. Traditional botanical knowledge and customs provide valuable practical information about potential therapeutic applications of a given plant.
Data from Colorado, which was among the first states to legalize marijuana, indicates that edible cannabis-infused products account for some 45% of all cannabis sales. Risks of over-consumption and accidental ingestion. Risks from the consumption of illicit or homemade edibles. Why Do People Like Marijuana Edibles?
There are many different methods of cannabis consumption these days; it’s not just about smoking joints, blunts, bowls, and bongs. The AHRQ told media, “Some data suggest that cannabinoids may have analgesic properties, though research in this area is mixed. A Statement from the AHRQ.
Nonetheless, with research into the plant’s pharmaceutical powers stacking up—cannabis has been proven to possess analgesic, anxiolytic, and anti-inflammatory effects — and state-legal markets reaping a slew of economic rewards— nationwide revenue topped $27 billion in 2021 — it’s not surprising that U.S. states and Washington, D.C.,
The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.
They offer a standardized process for making cannabis powder, highlight instruments, and demand high quality data. This small business has extraordinary ability, expertise, and intellectual property usually reserved for billion dollar pharmaceutical or public corporations. Grillo, Founder, Le Herbe.
The Shenzhen Stock Exchange Thursday sent letters to several companies, including Jilin Zixin Pharmaceutical Industrial Co. Even though growth and consumption of marijuana, the most common product of the cannabis plant, is illegal in China, it is legal to grow industrial hemp, also part of the cannabis family with less than 0.3%
The guidelines below detail some prime facets to consider in order to maintain high quality control standards in the cannabis research space: o Compliance with the Cannabis Act and the MRIA Code of Conduct including referencing the guidelines listed in the Pharmaceutical Research section.
To further complicate matters, the authority responsible for pharmaceutical regulation, the Austrian Federal Office for Safety in Health Care explicitly does not regard CBD products as functional drugs and does not recognise it as a medicinal product. According to official government data, more than 20 percent of Austria’s 8.77
The medical cannabis industry is coming to Brazil beyond imports of pharmaceutical-based cannabis medicines. . Brazil is currently a leading importer of pharmaceutical-based cannabis medicine. Pharmaceutical-based cannabis products are not effective for a large number of suffering patients in Brazil.
before unsavory political figures created laws to demonize its consumption—primarily to target immigrants and minorities. Some of the research that has been done is purely observational, and it is difficult to draw any concrete conclusions or produce hard data. Regulating Your Marijuana Consumption is Key.
If any weed company fails to compose all of this data on their product label, it may not be legal and doesn’t possess high quality. On the other side, reliable, honest corporations utilize herbal and pharmaceutical -grade grain alcohol to distill cannabinoids. Net Quantity Of The Product. Usage Instructions. Storage Instructions.
MJ Biz run the “New data reveals top medical conditions for which cannabis is reimbursed in Germany” story. New data reveals top medical conditions for which cannabis is reimbursed in Germany. The figure includes cannabis flower and oils, as well as pharmaceutical products like Sativex, Nabilone and Dronabinol.
Congruent to that mission of awareness is the fact that CBD acceptance is rising and so is consumption – especially in the United States. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S.
Operating at the intersection of big data, digital health, and natural products, Radicle Science leverages a proprietary data analytics platform and a virtual, direct-to-consumer (D2C) model to deliver objective health outcome data across diverse populations and conditions. Media Contact: Eric Schudiske ( eric@s2spr.com ).
The positive reputation we have built in the industry is reflected in our increasing customer satisfaction and consumption levels.”. The ecosystem created through its international operations leverages the Company’s unique data-driven perspective and product supply chain globally. Transaction Details. and Panaxia Logistics Ltd.,
The report, Nurturing new growth: Canada gets ready for Cannabis 2.0 , says the legalization on October 17, 2019 , of edibles containing cannabis and cannabis concentrates will create new product mixes that will reach consumers who may have been reluctant to try traditional cannabis consumption methods that are currently available.
The active substance THC may be used in pharmaceuticals, whereas the use of the hemp blossom as a drug is not permitted. According to the ministry the published data on the application of CBD in a recent pubmed-research are not sufficient for the assessment of a therapeutic effect. CBD therefore is not a medicinal product by function.
The public health minister said that as of May 2019, only six NHS prescriptions had been written since the changes to the Regulations came into effect and ten private prescriptions were written between January 2019 and February 2019 according to the NHS Business Services Authority, which collects data on primary care. Novel Foods Regulation.
New data from the Treasury Department’s Financial Crimes Enforcement Network shows a significant increase in the number of banks willing to work with cannabis businesses as cannabis financial services legislation gains momentum in Congress. Canadian pharmaceutical and cannabis company Tilray Inc.
Measure 1, Background of principals, board members, and owners: Applicants shall provide an overview of experience of principals, officers, and owners, in operating a regulated cannabis business, or operating a business in another highly regulated industry, such as healthcare, insurance, financial services, pharmaceuticals, or energy.
A ‘novel food’ is any ingredient which was not widely sold for human consumption within the European Union before a specific date in 1997. In many ways it may suit EFSA to declare that the data is inadequate and therefore the assessment couldn’t take place. Reports Health Europa.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content